Skip to content

Synergistic Effects of Repetitive Transcranial Magnetic Stimulation and a Dance Movement Intervention on Mild Cognitive Impairment: Study Protocol for a Four-Arm Factorial Randomized Controlled Trial

Repetitive Transcranial Magnetic Stimulation Plus Dance Movement Intervention for Mild Cognitive Impairment: A Factorial Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127655
Enrollment
Unknown
Registered
2026-07-03
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Combined Intervention:Active repetitive transcranial magnetic stimulation (rTMS) combined with square dance movement intervention. The rTMS is administered 5 times per week for the first 4 weeks, and
the square dance intervention is c
rTMS Intervention only:Active rTMS (intervention frequency is the same as Group 1) combined with a time-matched non-aerobic social activity control (3 times per week, 60 minutes per session).
Dance Movement Intervention (DMI) only:Sham rTMS stimulation (using a placebo coil that produces equivalent sound and somatosensory sensations but no actual magnetic field) combined with square dance
Control group:Sham rTMS stimulation combined with a time-matched non-aerobic social activity control.

Sponsors

Handan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of amnestic or multi-domain MCI by a specialist physician according to the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria. 2. Age between 50 and 85 years. 3. Montreal Cognitive Assessment (MoCA) score between 18 and 25. 4. Geriatric Depression Scale (GDS-15) score = 41). 6. Stable doses of any prescribed medications for at least 30 days prior to screening. 7. Sufficient visual and auditory acuity (with correction if necessary) to complete assessments and interventions. 8. Voluntarily agrees to participate and provides informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of dementia (any type). 2. Presence of major psychiatric conditions (e.g., major depressive disorder, schizophrenia) or neurological disorders (e.g., Parkinson’s disease, stroke) that could confound cognitive assessment. 3. Contraindications to rTMS (e.g., history of seizures, metallic implants in the head). 4. Regular participation in structured exercise (>= 3 times per week) or another cognitive intervention program within the past six months. 5. Abuse of drugs or alcohol that could cause cognitive impairment.

Design outcomes

Primary

MeasureTime frame
The Montreal Cognitive Assessment (MoCA);

Secondary

MeasureTime frame
Memory: Assessed using the Wechsler Memory Scale, Fourth Edition (WMS-IV);Executive Function: Evaluated via the Trail Making Test (Parts A and B);Physical Performance: Measured using the 6-Minute Walk Test (6MWT) for functional exercise capacity and the Berg Balance Scale (BBS) for static and dynamic balance. ;Quality of Life: Assessed using the 12-item Short Form Health Survey (SF-12);

Countries

China

Contacts

Public ContactQing He

Handan Central Hospital

Heqing9111@163.com+86 176 0090 8118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026